The key difference between Celexa and Cymbalta is in their drug class. Celexa is a selective serotonin reuptake inhibitor (SSRI), while
The key difference between Celexa and Cymbalta is in their drug class. Celexa is a selective serotonin reuptake inhibitor (SSRI), while
Citalopram (Celexa) and duloxetine (Cymbalta) are antidepressant medications used for the treatment of depression. Celexa belongs to a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), and Cymbalta belongs to the is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) drug class. The main difference between Celexa and Cymbalta is in how the they
Understanding the differences between these medications can help individuals make informed decisions about their mental health treatment options. Key Differences Between Celexa and Cymbalta Mechanism of Action. While both Celexa and Cymbalta are antidepressants, their mechanism of action differs.
The key difference between Celexa and Cymbalta is in their drug class. Celexa is a selective serotonin reuptake inhibitor (SSRI), while
Celexa (citalopram) vs. Cymbalta (duloxetine) quick comparison of differences ; Side effects of Celexa and Cymbalta that are similar include:. Nausea Dry mouth
The key difference between Celexa and Cymbalta is in their drug class. Celexa is a selective serotonin reuptake inhibitor (SSRI), while
The key difference between Celexa and Cymbalta is in their drug class. Celexa is a selective serotonin reuptake inhibitor (SSRI), while Cymbalta is a serotonin-norepinephrine reuptake inhibitor (SNRI). Although they are both antidepressants, Celexa and Cymbalta cannot be interchanged.
This comparison in between Cymbalta vs Celexa. Briefly put, both Cymbalta and Celexa differ in their mechanisms: Cymbalta is an SNRI targeting serotonin and norepinephrine, while Celexa is an SSRI primarily affecting serotonin. These distinctions influence their range of applications and potential effects. In the realm of mental health, finding the right medication to address
Comments